Turning Point Therapeutics Inc – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 79 pages Agreement and Plan of Merger Among: Turning Point Therapeutics, Inc., a Delaware Corporation; Bristol-Myers Squibb Company, a Delaware Corporation; and Rhumba Merger Sub Inc., a Delaware Corporation Dated as of June 2, 2022